http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34718302

Outgoing Links

Predicate Object
contentType Journal Article|Review
issn 2234-943X
pageRange 1036437-
publicationName Frontiers in Oncology
startingPage 1036437
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_dee036e759c010e5dbb2a0639c301310
bibliographicCitation Qian H, Gang D, He X, Jiang S. A review of the therapeutic role of the new third-generation TKI olverembatinib in chronic myeloid leukemia. Front Oncol. 2022;12():1036437. PMID: 36568202; PMCID: PMC9772831.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8cddafd2e6cf6605471637ae9d79694f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f84148c73664609fcece3c097c9e81c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e708bdf3abcc241ebe33845d7335689a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a8e341fdd581b465dd931dfcbdf4d63
date 2022-12-08^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/36568202
https://doi.org/10.3389/fonc.2022.1036437
https://pubmed.ncbi.nlm.nih.gov/PMC9772831
isPartOf https://portal.issn.org/resource/ISSN/2234-943X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39509
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title A review of the therapeutic role of the new third-generation TKI olverembatinib in chronic myeloid leukemia
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11043
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10833
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51038269
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431

Showing number of triples: 1 to 28 of 28.